Skip to content

To study the effectiveness of moist occlusive honey dressing vs. Jatyadi Taila dressing in complete healing of Vrana (wound)

A prospective randomized clinical study to compare the effectiveness of moist occlusive honey dressing vs. Jatyadi Taila dressing in complete healing of Vrana (wound)

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/04/032558
Enrollment
40
Registered
2021-04-06
Start date
Unknown
Completion date
Unknown
Last updated
2022-11-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L988- Other specified disorders of the skin and subcutaneous tissue

Interventions

Intervention1: Jatyadi Taila: Dose- Sufficient quantity (approx.10 ml) of Jatyadi Taila Route of administration- Local application Frequency- On alternate day Duration- Up to 6 weeks Control Interven

Sponsors

All India Institute of Ayurveda
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Any wound on trunk or limbs in 18-60 years old adults caused by injury or surgery. 2. Patients between age 18-60 years with an informed signed consent visiting the outpatient clinic of AIIA, or those admitted to the indoor wards of AIIA and shall be recruited in the study if they have a wound on trunk or limbs as above. 3. Patients presenting with chronic wounds will be initially treated with daily dressing cleansing with normal saline and dressing with paraffin gauze along with surgical debridement. 4. Presence of diabetes will be included in the study with appropriate correction of their body physiology.

Exclusion criteria

Exclusion criteria: 1. Patient not able to understand or sign the consent or those not being able to visit the clinic will be excluded. 2. Wound size > 5cm in maximum diameter. 3. Known allergy to honey, Taila and Tegaderm. 4. Patients suffering from wounds like, Leprotic ulcer, Tubercular ulcer. 5. Patients suffering from malignant ulcers. 6. Patients with Hepatitis, AIDS & STD.

Design outcomes

Primary

MeasureTime frame
Reduction of Wound size and healing within 6 weeks.Timepoint: 0th day, 14th day, 28th day, 42nd day

Secondary

MeasureTime frame
1. Decrease in pain score on VAS 2. Cost effectiveness of dressing 3. Overall satisfaction with dressingTimepoint: 0th day, 14th day, 28th day, 42nd day

Countries

India

Contacts

Public ContactDr V D Mahanta

All India Institute of Ayurveda

drvyasayu@yahoo.in8368104072

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026